天天精品资源在线观看,亚洲精品在线影院,女性私人爽爽影院免费观看国产,亚洲中文字幕aⅴ天堂自拍

  • Advances In Integrative Medicine
    • 數(shù)據(jù)庫收錄SCIE
    • 年發(fā)文量19

    Advances In Integrative Medicine

    期刊中文名:綜合醫(yī)學(xué)的進(jìn)展ISSN:2212-9626E-ISSN:2212-9634

    該雜志國(guó)際簡(jiǎn)稱:ADV INTEGR MED,是由出版商Elsevier出版的一本致力于發(fā)布--研究新成果的的專業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有很高的學(xué)術(shù)影響力。

    基本信息:
    期刊簡(jiǎn)稱:ADV INTEGR MED
    是否OA:開放
    是否預(yù)警:
    Gold OA文章占比:4.17%
    出版信息:
    出版地區(qū):Netherlands
    出版語言:English
    出版商:Elsevier
    評(píng)價(jià)信息:
    JCR分區(qū):Q3
    影響因子:1.2
    CiteScore:3.2
    雜志介紹 JCR分區(qū) CiteScore 投稿經(jīng)驗(yàn)

    雜志介紹

    Advances In Integrative Medicine雜志介紹

    《Advances In Integrative Medicine》是一本以English為主的開放獲取國(guó)際優(yōu)秀期刊,中文名稱綜合醫(yī)學(xué)的進(jìn)展,本刊主要出版、報(bào)道領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為1.2,最新CiteScore 指數(shù)為3.2。

    英文介紹

    Advances In Integrative Medicine雜志英文介紹

    The Journal of Advances in Integrative Medicine is renowned for its high standards of scientific publication and rigorous review process. It adopts an international standard double-blind review system to ensure that each manuscript undergoes rigorous review by professional scholars and experts, ensuring the scientific, innovative, and reliable nature of its content. Its publication scope is extensive, covering multiple fields such as traditional Chinese and Western medicine and dietary therapy, joint research between traditional Chinese medicine and Western medicine, the latest developments in precision medicine, and the impact of genomics on disease prevention and treatment. It comprehensively focuses on the full lifecycle management of diseases, including new technologies, methods, and products related to disease occurrence and development, screening and early warning, diagnostic typing, treatment intervention, and prognosis.

    In addition, the journal also focuses on the challenges and opportunities in the global health field, as well as the importance of equal access to healthcare for all, and is committed to promoting the development and popularization of integrated medicine on a global scale. Its international editorial team and open access publishing strategy further promote the widespread dissemination and collaborative exchange of academic achievements.

    JCR分區(qū)(2023-2024年最新版)

    Advances In Integrative Medicine雜志 JCR分區(qū)信息

    按JIF指標(biāo)學(xué)科分區(qū)
    學(xué)科:INTEGRATIVE & COMPLEMENTARY MEDICINE
    收錄子集:ESCI
    分區(qū):Q3
    排名:28 / 43
    百分位:

    36%

    按JCI指標(biāo)學(xué)科分區(qū)
    學(xué)科:INTEGRATIVE & COMPLEMENTARY MEDICINE
    收錄子集:ESCI
    分區(qū):Q3
    排名:30 / 43
    百分位:

    31.4%

    JCR分區(qū):JCR分區(qū)來自科睿唯安公司,JCR是一個(gè)獨(dú)特的多學(xué)科期刊評(píng)價(jià)工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評(píng)價(jià)資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個(gè)具體學(xué)科。JCR分區(qū)根據(jù)每個(gè)學(xué)科分類按照期刊當(dāng)年的影響因子高低將期刊平均分為4個(gè)區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個(gè)部分的。

    CiteScore 評(píng)價(jià)數(shù)據(jù)(2024年最新版)

    Advances In Integrative Medicine雜志CiteScore 評(píng)價(jià)數(shù)據(jù)

    • CiteScore 值:3.2
    • SJR:0.329
    • SNIP:0.493
    學(xué)科類別 分區(qū) 排名 百分位
    大類:Medicine 小類:Complementary and Alternative Medicine Q2 39 / 105

    63%

    歷年影響因子和期刊自引率

    投稿經(jīng)驗(yàn)

    Advances In Integrative Medicine雜志投稿經(jīng)驗(yàn)

    該雜志是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有較高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國(guó)際權(quán)威數(shù)據(jù)庫SCIE收錄,該雜志在綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高,作為一本國(guó)際優(yōu)秀雜志,一般投稿過審時(shí)間都較長(zhǎng),投稿過審時(shí)間平均 15 Weeks ,如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請(qǐng)咨詢客服。

    免責(zé)聲明

    若用戶需要出版服務(wù),請(qǐng)聯(lián)系出版商。